摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,8-Dimethoxy-5H-imidazo[1,5-a]quinoxalin-4-one | 221068-29-7

中文名称
——
中文别名
——
英文名称
7,8-Dimethoxy-5H-imidazo[1,5-a]quinoxalin-4-one
英文别名
——
7,8-Dimethoxy-5H-imidazo[1,5-a]quinoxalin-4-one化学式
CAS
221068-29-7
化学式
C12H11N3O3
mdl
MFCD27414834
分子量
245.238
InChiKey
IZMUQGJWBDCVJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >250 °C
  • 沸点:
    356.1±42.0 °C(Predicted)
  • 密度:
    1.45±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    65.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency
    摘要:
    A series of anilino(imidazoquinoxaline) analogues bearing solubilizing side chains at the 6- and 7-positions of the fused phenyl ring has been prepared and evaluated for inhibition against Lck enzyme and of T-cell proliferation. Significant improvement of the cellular activity was achieved over the initial lead, compound 2. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00677-7
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency
    摘要:
    A series of anilino(imidazoquinoxaline) analogues bearing solubilizing side chains at the 6- and 7-positions of the fused phenyl ring has been prepared and evaluated for inhibition against Lck enzyme and of T-cell proliferation. Significant improvement of the cellular activity was achieved over the initial lead, compound 2. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00677-7
点击查看最新优质反应信息

文献信息

  • A New Strategy for the Construction of the Imidazo[1,5-<i>a</i>]quinoxalin-4-one Ring System and Its Application to the Efficient Synthesis of BMS-238497, a Novel and Potent Lck Inhibitor
    作者:Bang-Chi Chen、Rulin Zhao、Mark S. Bednarz、Bei Wang、Joseph E. Sundeen、Joel C. Barrish
    DOI:10.1021/jo0355348
    日期:2004.2.1
    ring system. The new method involves condensation of o-nitroaniline with glyoxylate in methanol followed by treatment of the resulting α-(o-nitroanilino)-α-methoxy acetate with tosylmethyl isocyanide (TosMIC) reagent to give 1-(o-nitrophenyl)imidazole-5-carboxylate. Reductive cyclization of the nitro imidazole carboxylate afforded imidazo[1,5-a]quinoxalin-4-one in three steps and 60% overall yield. The
    为构建咪唑并[1,5 - a ]喹喔啉-4-一环系统开发了一种新的有效策略。新方法涉及将邻硝基苯胺与乙醛酸酯在甲醇中缩合,然后用甲苯磺酰基甲基异氰化物(TosMIC)试剂处理所得的α-(邻硝基苯胺基)-α-甲氧基乙酸酯,得到1-(邻硝基苯基)咪唑-5 -羧酸盐。硝基咪唑羧酸盐的还原环化以三个步骤提供咪唑并[1,5 - a ]喹喔啉-4-酮,总产率为60%。该新方法已成功应用于合成新型有效的Lck抑制剂BMS-238497。
  • Reaction of quinoxalin-2-ones with TosMIC reagent: synthesis of imidazo[1,5-a]quinoxalin-4-ones
    作者:Ping Chen、Joel C. Barrish、Edwin Iwanowicz、James Lin、Mark S. Bednarz、Bang-Chi Chen
    DOI:10.1016/s0040-4039(01)00697-9
    日期:2001.6
    Imidazo[1,5-alpha ]quinoxalin-4-ones were prepared in four steps starting from 1,2-phenylenediamines using a new strategy for the construction of the ring system. A key step in this new method involves the reaction of quinoxalin-2-ones with TosMIC (tosylmethyl isocyanide). (C) 2001 Elsevier Science Ltd. All rights reserved.
  • US6235740B1
    申请人:——
    公开号:US6235740B1
    公开(公告)日:2001-05-22
  • Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency
    作者:Ping Chen、Edwin J. Iwanowicz、Derek Norris、Henry H. Gu、James Lin、Robert V. Moquin、Jagabandhu Das、John Wityak、Steven H. Spergel、Henry de Fex、Suhong Pang、Sydney Pitt、Ding Ren Shen、Gary L. Schieven、Joel C. Barrish
    DOI:10.1016/s0960-894x(02)00677-7
    日期:2002.11
    A series of anilino(imidazoquinoxaline) analogues bearing solubilizing side chains at the 6- and 7-positions of the fused phenyl ring has been prepared and evaluated for inhibition against Lck enzyme and of T-cell proliferation. Significant improvement of the cellular activity was achieved over the initial lead, compound 2. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多